Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older

NCT02160340 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1584

Last updated 2018-03-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate the prevalence of vitreomacular adhesion (VMA) in patients 40 years and older using Spectral Domain Optical Coherence Tomography.

Conditions

  • Vitreomacular Adhesion

Sponsors & Collaborators

  • ThromboGenics

    collaborator INDUSTRY
  • Carl Zeiss Meditec, Inc.

    collaborator INDUSTRY
  • Optovue

    collaborator INDUSTRY
  • Nova Southeastern University

    lead OTHER

Principal Investigators

  • Julie A Rodman, OD, MS, FAAO · Nova Southeastern University

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-01-31
Completion
2017-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02160340 on ClinicalTrials.gov